Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Optimal Treatment Strategy Based on for Pediatric AML
ClinicalTrials.gov study NCT02848183. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS
ClinicalTrials.gov study NCT02267863. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
ClinicalTrials.gov study NCT06885476. IPD Sharing: NO. Countries: 1. Publications: 0.
CER-1236 in Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06834282. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML
ClinicalTrials.gov study NCT05471323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Multicenter Clinical Trial of MRD-based Treatment Strategy in Children and Young Adults With AML
ClinicalTrials.gov study NCT03846362. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
ClinicalTrials.gov study NCT05215639. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
ClinicalTrials.gov study NCT02926586. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AML Treatment in Untreated Adult Patients
ClinicalTrials.gov study NCT00449319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TAS1440 With ATRA in Subjects With r/r AML
ClinicalTrials.gov study NCT04282668. IPD Sharing: NO. Countries: 1. Publications: 0.
CART-38 in Adult AML and MM Patients
ClinicalTrials.gov study NCT05442580. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
ClinicalTrials.gov study NCT05101551. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04509622. IPD Sharing: YES. Countries: 1. Publications: 0.
Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludar
ClinicalTrials.gov study NCT00915811. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
ClinicalTrials.gov study NCT01639456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03672539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dexamethasone Added to Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03609060. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
ClinicalTrials.gov study NCT06514261. IPD Sharing: YES. Countries: 1. Publications: 0.
Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01723657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML
ClinicalTrials.gov study NCT05054543. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.